Catalysts for Accord Healthcare Inc
128 tracked
Apr 22, 2026
drug shortage
Atropine Sulfate Injection shortage โ Hospira, Inc., a Pfizer Company
Accord Healthcare Inc
โ
Apr 21, 2026
drug shortage
Dexmedetomidine Hydrochloride Injection shortage โ Accord Healthcare Inc.
Accord Healthcare Inc
โ
Apr 20, 2026
approval
DALFAMPRIDINE โ FDA approval
dalfampridine ER
โ
Apr 15, 2026
drug shortage
Clonazepam Tablet shortage โ Accord Healthcare Inc.
Accord Healthcare Inc
โ
Apr 15, 2026
drug shortage
Carboplatin Injection shortage โ Accord Healthcare Inc.
Accord Healthcare Inc
โ
Apr 15, 2026
drug shortage
Atropine Sulfate Injection shortage โ Accord Healthcare Inc.
Accord Healthcare Inc
โ
Apr 15, 2026
drug shortage
Methotrexate Sodium Injection shortage โ Accord Healthcare Inc.
Accord Healthcare Inc
โ
Mar 18, 2026
approval
ATROPINE SULFATE โ FDA approval
ATROPINE SULFATE
โ
Mar 18, 2026
approval
VIGABATRIN โ FDA approval
VIGABATRIN
โ
Mar 17, 2026
approval
OXALIPLATIN โ FDA approval
OXALIPLATIN
โ
Mar 17, 2026
approval
OXALIPLATIN โ FDA approval
OXALIPLATIN
โ
Mar 13, 2026
approval
METHOTREXATE โ FDA approval
Maxtrex
โ
Feb 5, 2026
approval
FLUOROURACIL โ FDA approval
Efudex
โ
Feb 5, 2026
approval
FLUOROURACIL โ FDA approval
Efudex
โ
Feb 4, 2026
approval
ATROPINE SULFATE โ FDA approval
ATROPINE SULFATE
โ
Feb 3, 2026
approval
IBANDRONATE SODIUM โ FDA approval
IBANDRONATE SODIUM
โ
Jan 26, 2026
approval
DAPTOMYCIN โ FDA approval
Daptomycin Novo
โ
Jan 7, 2026
approval
QUETIAPINE FUMARATE โ FDA approval
quetiapine fumarate ER
โ
Nov 25, 2025
approval
ACETAZOLAMIDE โ FDA approval
Accord Healthcare Inc
โ
Nov 14, 2025
approval
LENALIDOMIDE โ FDA approval
LENALIDOMIDE
โ
Nov 13, 2025
approval
ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE (ONDANSETRON HYDROCHLORIDE) โ FDA approval
ondansetron hydrochloride CR
โ
Oct 28, 2025
approval
ENLON-PLUS (ATROPINE SULFATE) โ FDA approval
Accord Healthcare Inc
โ
Oct 28, 2025
approval
ENLON-PLUS (ATROPINE SULFATE) โ FDA approval
Accord Healthcare Inc
โ
Oct 3, 2025
approval
CLOMIPHENE CITRATE โ FDA approval
CLOMIPHENE CITRATE
โ
Oct 1, 2025
approval
LETROZOLE โ FDA approval
LETROZOLE
โ
Oct 1, 2025
approval
LETROZOLE โ FDA approval
LETROZOLE
โ
Oct 1, 2025
approval
DIAMOX (ACETAZOLAMIDE) โ FDA approval
Accord Healthcare Inc
โ
Jul 25, 2025
approval
IBANDRONATE SODIUM โ FDA approval
IBANDRONATE SODIUM
โ
May 29, 2025
approval
METHOTREXATE โ FDA approval
Maxtrex
โ
Feb 18, 2025
approval
ATROPINE SULFATE โ FDA approval
ATROPINE SULFATE
โ